Skip to main content

Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects

مؤلف البحث
Gaber El-Saber Batiha , Ali Alqahtani , Omotayo B. Ilesanmi , Abdullah A. Saati , Amany El-Mleeh , Helal F. Hetta and Amany Magdy Beshbishy
مجلة البحث
Pharmaceuticals
المشارك في البحث
الناشر
MDPI
تصنيف البحث
1
عدد البحث
13
موقع البحث
https://www.mdpi.com/1424-8247/13/8/196/htm
سنة البحث
2020
صفحات البحث
196
ملخص البحث

Avermectins are a group of drugs that occurs naturally as a product of fermenting Streptomyces avermitilis, an actinomycetes, isolated from the soil. Eight different structures, including ivermectin, abamectin, doramectin, eprinomectin, moxidectin, and selamectin, were isolated and divided into four major components (A1a, A2a, B1a and B2a) and four minor components (A1b, A2b, B1b, and B2b). Avermectins are generally used as a pesticide for the treatment of pests and parasitic worms as a result of their anthelmintic and insecticidal properties. Additionally, they possess anticancer, anti-diabetic, antiviral, antifungal, and are used for treatment of several metabolic disorders. Avermectin generally works by preventing the transmission of electrical impulse in the muscle and nerves of invertebrates, by amplifying the glutamate effects on the invertebrates-specific gated chloride channel. Avermectin has unwanted effects or reactions, especially when administered indiscriminately, which include respiratory failure, hypotension, and coma. The current review examines the mechanism of actions, biosynthesis, safety, pharmacokinetics, biological toxicity and activities of avermectins.